These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23235629)

  • 1. Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients.
    Mulder RL; Paulides M; Langer T; Kremer LC; van Dalen EC
    Cochrane Database Syst Rev; 2012 Dec; 12():CD006300. PubMed ID: 23235629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients.
    Mulder RL; Paulides M; Langer T; Kremer LC; van Dalen EC
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD006300. PubMed ID: 26421585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients.
    Mulder RL; Paulides M; Langer T; Kremer LC; van Dalen EC
    Cochrane Database Syst Rev; 2010 Feb; (2):CD006300. PubMed ID: 20166081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate for high-grade osteosarcoma in children and young adults.
    van Dalen EC; de Camargo B
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006325. PubMed ID: 19160278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.
    van Dalen EC; Raphaël MF; Caron HN; Kremer LC
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD006647. PubMed ID: 25188452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose ifosfamide as second- or third-line chemotherapy in refractory bone and soft tissue sarcoma patients.
    Lee SH; Chang MH; Baek KK; Han B; Lim T; Lee J; Park JO
    Oncology; 2011; 80(3-4):257-61. PubMed ID: 21734417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group.
    Bramwell VH; Mouridsen HT; Santoro A; Blackledge G; Somers R; Verweij J; Dombernowsky P; Onsrud M; Thomas D; Sylvester R
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S180-4. PubMed ID: 8453694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.
    van Dalen EC; Raphaël MF; Caron HN; Kremer LC
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006647. PubMed ID: 19160293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.
    van Dalen EC; Raphaël MF; Caron HN; Kremer LC
    Cochrane Database Syst Rev; 2011 Jan; (1):CD006647. PubMed ID: 21249679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate for high-grade osteosarcoma in children and young adults.
    van Dalen EC; van As JW; de Camargo B
    Cochrane Database Syst Rev; 2011 May; 2011(5):CD006325. PubMed ID: 21563152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma Group.
    Blackledge G; Steward WP; Verweij J; Mouridsen H; Bramwell V; Schütte J; van Oosterom A; Dombernowsky P; Buesa J; Van Glabekke M
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):14-8. PubMed ID: 1411615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose ifosfamide in the treatment of sarcomas of soft tissues and bone.
    Demetri GD
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):22-6. PubMed ID: 8677444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).
    Sleijfer S; Ouali M; van Glabbeke M; Krarup-Hansen A; Rodenhuis S; Le Cesne A; Hogendoorn PC; Verweij J; Blay JY
    Eur J Cancer; 2010 Jan; 46(1):72-83. PubMed ID: 19853437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
    Yalçin B; Kremer LC; Caron HN; van Dalen EC
    Cochrane Database Syst Rev; 2013 Aug; (8):CD006301. PubMed ID: 23970444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
    Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Continuous-infusion high dose ifosfamide as salvage treatment for pre-treated soft tissue sarcoma].
    Chen LK; Xu GC; Teng XY; Liang Y; Liu JL; Zhou XM
    Ai Zheng; 2002 Aug; 21(8):903-6. PubMed ID: 12478904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ifosfamide in pediatric malignancy--experiences in the Northern Israel Oncology Center].
    Roguin A; Ben Arush MW; Higasi A; Kuten A
    Harefuah; 1996 Apr; 130(8):511-4, 584. PubMed ID: 8765870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
    Judson I; Verweij J; Gelderblom H; Hartmann JT; Schöffski P; Blay JY; Kerst JM; Sufliarsky J; Whelan J; Hohenberger P; Krarup-Hansen A; Alcindor T; Marreaud S; Litière S; Hermans C; Fisher C; Hogendoorn PC; dei Tos AP; van der Graaf WT;
    Lancet Oncol; 2014 Apr; 15(4):415-23. PubMed ID: 24618336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose ifosfamide with hematopoietic growth factor support in advanced bone and soft tissue sarcomas.
    Yalcin B; Pamir A; Buyukcelik A; Utkan G; Akbulut H; Demirkazik A; Icli F
    Exp Oncol; 2004 Dec; 26(4):320-5. PubMed ID: 15627067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children.
    de Lijster MS; Bergevoet RM; van Dalen EC; Michiels EM; Caron HN; Kremer LC; Aronson DC
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008403. PubMed ID: 20238368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.